Consequently, research offers focused on the therapeutic role of 5-HT3 receptor antagonists in NC-IBD, particularly in IBS-D
Consequently, research offers focused on the therapeutic role of 5-HT3 receptor antagonists in NC-IBD, particularly in IBS-D. 0.82), cilansetron showed the best overall performance (SUCRA 0.90) for abdominal pain/distress improvement, while ondansetron (SUCRA 0.98) was undoubtedly the best choice concerning bowel practices/regularity improvement. The control regimens (mebeverine and placebo) displayed ATI-2341 the least efficacious interventions.…